NYSE: POL), a premier provider of specialized polymer materials, services and solutions, today announced two internal appointments effective His most recent position was vice president, Internal Audit, and corporate ethics officer.

LubriOne™ Internally Lubricated Formulations Internally Lubricated Formulations: LubriOne™

LubriOne™ Internally Lubricated Formulations Internally Lubricated Formulations: LubriOne™

For the plastics used in these medical applications, this can mean compliance with the relevant chapters of the International Organization for Standardization (ISO), the United States Pharmacopeia Class VI (USP VI) the European Pharmacopeia (EP 3.1), and the International Conference on Harmonization (ICH Q3D) standards and guidelines.

For the plastics used in these medical applications, this can mean compliance with the relevant chapters of the International Organization for Standardization (ISO), the United States Pharmacopeia Class VI (USP VI) the European Pharmacopeia (EP 3.1), and the International Conference on Harmonization (ICH Q3D) standards and guidelines.

This innovative solution helped Resol to win two international awards recognizing the inventive design and use of engineering thermoplastics. Awards for the Vela table include the German Design Council’s Interior Innovation Award 2014, and the International Interior Design Association (IIDA) Best of Category award in its 2014 Product Design Competition.

CLEVELAND – PolyOne Corporation (NYSE: POL), a premier global provider of specialized polymer materials, services and solutions, will feature the latest technologies for packaging applications at PACK EXPO International 2014 this week in Chicago. PACK EXPO International, one of the most highly regarded packaging exhibitions in the world, is held annually and features the latest innovations and trends in the processing and packaging industry.

LubriOne™ Internally Lubricated Formulations Internally Lubricated Formulations: LubriOne™

For the plastics used in these medical applications, this can mean compliance with the relevant chapters of the International Organization for Standardization (ISO), the United States Pharmacopeia Class VI (USP VI) the European Pharmacopeia (EP 3.1), and the International Conference on Harmonization (ICH Q3D) standards and guidelines.

Jellison, 57, is vice president and chief financial officer of Stryker Corporation (NYSE: SYK), one of the world’s leading medical technology companies, where he is responsible for all areas of international finance, including accounting, planning and analysis, SEC reporting, acquisition valuations, internal audit, tax and treasury.